
Albert August Volkl RPh, DPh, PharmD
Critical Care Pharmacy, Oncology Pharmacy, Pharmacotherapy
Join to View Full Profile
176 Lee AvenueBrooklyn, NY 11201
Albert August Volkl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Certifications & Licensure
- Board of Pharmacy Specialties (BPS) Pharmacotherapy
Education & Training
- St. John's UniversityPharmD, 1993
Publications & Presentations
PubMed
- 3 citationsUpdated Renal Dosage Recommendations for Rivaroxaban in Patients Experiencing or at Risk of Thromboembolic Disease.Albert A Volkl, Kenneth Todd Moore, Lloyd Haskell, Elliot S Barnathan
American Journal of Cardiovascular Drugs. 2023-05-01 - 167 citationsA Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.George D Dangas, Jan G P Tijssen, Jochen Wöhrle, Lars Søndergaard, Martine Gilard
The New England Journal of Medicine. 2020-01-09 - 79 citationsTrial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO studyStephan Windecker, Jan Tijssen, Gennaro Giustino, Ana H.C. Guimarães, Roxana Mehran
American Heart Journal. 2017-02-01
Journal Articles
- Benefit Risk Assessment of Rivaroxaban in NonValvular Atrial Fibrillation or Venous ThrombosisVolkl A, Drugs and Aging, 3/31/2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: